Prevalence of mood disorders and anxiety in people with epilepsy: a systematic review

Authors

DOI:

https://doi.org/10.11606/issn.1679-9836.v103i4e-226358

Keywords:

Epilepsy, Mood Disorders, Anxiety Disorders, Prevalence

Abstract

Background: Epilepsy is recognized as a group of chronic non-transmissible diseases that have recurrent epileptic seizures in common, and is associated with a greater predisposition to psychiatric comorbidities. Although mood and anxiety disorders frequently occur in people with epilepsy (PWE) and impair quality of life and treatment outcomes, current studies to investigate these comorbidities remain with unsatisfactory results for the epilepsy population in developing countries. Objectives: To describe the frequency of mood and anxiety disorders and the clinical and sociodemographic characteristics of people with epilepsy presenting with these disorders. Methods: Literature review in EMBASE, LILACS, PsycINFO, Pubmed, and Scielo databases. Cross-sectional studies published in the last 5 years in Portuguese and English language were included, and that evaluated comorbidities in individuals aged 18 years or older with a diagnosis of epilepsy facing the International League Against Epilepsy criteria. Results: Our search tracked 3,054 articles, of which 3047 were excluded for duplicate publication and for being incompatible with the topic due to eligibility criteria. The results found for psychiatric diagnoses ranged from 18% to 52.6% for the prevalence of mood disorders and 6.5% to 33.4% for anxiety disorders. Conclusion: This review found a higher prevalence of mood and anxiety disorders in PWE. Thus, physicians responsible for treating people with epilepsy should be aware of the increased chances of mood and anxiety disorders in this population in order to take an appropriate approach to these patients.

Downloads

Download data is not yet available.

References

Who.int. 2021. Epilepsy. WHO. 2021. https://www.who.int/news-room/factsheets/detail/epilepsy.

Mula M, Kanner AM, Jetté N, Sander JW. Psychiatric Comorbidities in People With Epilepsy. Neurol Clin Pract. 2021;11:e112-20. Doi: https://doi.org/10.1212/CPJ.0000000000000874.

Allers K, Essue BM, Hackett ML, Muhunthan J, Craig S. The economic impact of epilepsy: a systematic review. BMC Neurol. 2015;15(1):245. Doi: https://doi.org/10.1186/s12883-015-0494-y

Ngugi AK, Kariuki SM, Bottomley C, Kleinschmidt I, Sander JW, Newton CR. Incidence of epilepsy: A systematic review and metaanalysis. Neurology. 2011;77(10):1005-12. Doi: https://doi.org/10.1212/wnl.0b013e31822cfc90

Li LM, Fernandes PT, Noronha ALA, Marques LHN, Borges MA, Cendes F, et al.. Demonstration project on epilepsy in Brazil: situation assessment. Arq Neuro-Psiquiatr [Internet]. 2007;65:5-13. Doi: https://doi.org/10.1590/S0004-282X2007001000002

Sen A, Jette N, Husain M, Sander JW. Epilepsy in older people. The Lancet 2020;395:735-48. Doi: https://doi.org/10.1016/S0140-6736(19)33064-8.

Kobau R, Gilliam F, Thurman DJ. Prevalence of self-reported epilepsy or seizure disorder and its associations with self-reported depression and anxiety: results from the 2004 healthstyles survey. Epilepsia. 2006;47(11):1915-21. Doi: https://doi.org/10.1111/j.1528-1167.2006.00612.x

Mula M, von Oertzen TJ, Cock HR, Lozsadi DA, Agrawal N. Clinical correlates of memory complaints during AED treatment. Acta Neurol Scand. 2016;134(5):368-73. Doi: https://doi.org/10.1111/ane.12553

Nogueira MH, Yasuda CL, Coan AC,Kanner AM, Cendes F. Concurrent mood and anxiety disorders ar associated with pharmacoresistant seizures in patients with MTLE. Epilepsia. 2017;58(7):1268-76. Doi: https://doi.org/10.1111/epi.13781

Gómez-Arias B, Crail-Meléndez D, López-Zapata R, Martínez-Juárez IE. Severity of anxiety and depression are related to a higher perception of adverse effects of antiepileptic drugs. Seizure. 2012;21(8):588-94. Doi: https://doi.org/10.1016/j.seizure.2012.06.003

Hitiris N, Mohanraj R, Norrie J, Sills G, Brodie MJ. Predictors of pharmacoresistant epilepsy. Epilepsy Res. 2007;75(2–3):192-6. Doi: https://doi.org/10.1016/j.eplepsyres.2007.06.003

Mesraoua B, Deleu D, Hassan AH, Gayane M, Ali MA, Tomson T, et al. Dramatic outcomes in epilepsy: depression, suicide, injuries, and mortality. Curr Med Res Opin. 2020;36(9):1473-80. Doi: https://doi.org/10.1080/03007995.2020.1776234

Patel AD, Baca C, Franklin G, Herman ST, Hughes I, Meunier L, et al. Quality improvement in neurology: Epilep Qual Measur. 2017;91(18):829-36. Doi: https://doi.org/10.1212/wnl.0000000000006425

Lopez MR, Schachter SC, Kanner AM. Psychiatric comorbidities go unrecognized in patients with epilepsy: “You see what you know”. Epilepsy Behav. 2019;98:302-5. Doi: https://doi.org/10.1016/j.yebeh.2019.01.027

Mula M, Cock HR. More than seizures: improving the lives of people with refractory epilepsy. Eur J Neurol. 2015;22(1):24-30. Doi: https://doi.org/10.1111/ene.12603

Pham T, Sauro KM, Patten SB, et al. The prevalence of anxiety and associated factors in persons with epilepsy. Epilepsia. 2017;58(8):e107–10. https://doi.org/10.1111/epi.13817

Amruth G, Praveen-Kumar S, Nataraju B, Kasturi P. Study of psychiatric comorbidities in epilepsy by using the Mini International Neuropsychiatric Interview. Epilepsy Behav. 2014;33:94-100. Doi: https://doi.org/10.1016/j.yebeh.2014.02.001

Chaka A, Awoke T, Yohannis Z, Ayano G, Tareke M, Abate A. Determinants of depression among people with epilepsy in Central Ethiopia. Ann Gen Psychiat. 2018;17:27. Doi: https://doi.org/10.1186/s12991-018-0197-z.

Wang H-J, Tan G, Deng Y, He J, He YJ, Zhou D, et al. Prevalence and risk factors of depression and anxiety among patients with convulsive epilepsy in rural West China. Acta Neurol Scand. 2018;138:541-7. Doi: https://doi.org/10.1111/ane.13016.

Kuladee S, Prachason T, Srisopit P, Trakulchang D, Boongird A, Wisajan P, et al. Prevalence of psychiatric disorders in Thai patients with epilepsy. Epilepsy Behav. 2019;90:20-4. Doi: https://doi.org/10.1016/j.yebeh.2018.11.004.

Grzegorzewska AM, Wiglusz MS, Landowski J, Jakuszkowiak-Wojten K, Cubała W, Włodarczyk A, et al. Multiple Comorbidity Profile of Psychiatric Disorders in Epilepsy. JCM. 2021;10:4104. Doi: https://doi.org/10.3390/jcm10184104.

Zhong R, Chen Q, Li N, et al. Sex-based differences in the prevalence of and risk factors for depression in adult patients with epilepsy in Northeast China. Epilepsy Behav. 2021;122:108201. https://doi.org/10.1016/j.yebeh.2021.108201.

Zhong R, Chen Q, Li M, Li N, Zhang X, Lin W. Sex differences in anxiety in patients with epilepsy: Status and risk factors analysis. Epilepsy Behav. 2021;116. Doi: https://doi.org/10.1016/j.yebeh.2021.107801.

Kanner AM. The Complex Epilepsy Patient: Intricacies of Assessment and Treatment. Epilepsia. 2003;44(Suppl.5):S3-S8. Doi: https://doi.org/10.1046/j.1528-1157.44.s.5.2.x

Bragatti JA, Torres CM, Londero RG, Martin KC, Souza AC, Hidalgo MPL, et al. Prevalence of psychiatric comorbidities in temporal lobe epilepsy in a Southern Brazilian population. Arq Neuro-Psiquiatr. 2011;69:159-65. Doi: https://doi.org/10.1590/S0004-282X2011000200003.

Who.int. Depression. n.d. WHO. 2021. https://www.who.int/news-room/fact-sheets/detail/depression.

Who int. Depression and other common mental disorders: global health estimates [Internet]. Geneva: WHO. 2017. http://apps.who.int/iris/bitstream/10665/254610/1/WHO-MSD-MER-2017.2-eng.pdf

Josephson CB, Jetté N. Psychiatric comorbidities in epilepsy. International Review of Psychiatry. 2017;29:409-24. Doi: https://doi.org/10.1080/09540261.2017.1302412.

Scott AJ, Sharpe L, Hunt C, Gandy M. Anxiety and depressive disorders in people with epilepsy: A meta-analysis. Epilepsia. 2017;58:973–82. Doi: https://doi.org/10.1111/epi.13769.

Kanner AM. Psychiatric issues in epilepsy: The complex relation of mood, anxiety disorders, and epilepsy. Epilepsy Behav. 2009;15:83-7. Doi: https://doi.org/10.1016/j.yebeh.2009.02.034.

Vazquez B, Devinsky O. Epilepsy and anxiety. Epilepsy & Behavior. 2003;4:20-5. Doi: https://doi.org/10.1016/j.yebeh.2003.10.005.

Kanner AM. Depression in epilepsy: a complex relation with unexpected consequences. Curr Opin Neurol. 2008;21:190-4. Doi: https://doi.org/10.1097/WCO.0b013e3282f4e978.

Torres, C. Fatores de risco para transtornos de ansiedade na epilepsia do lobo temporal. [Internet] 2010. http://www.lume.ufrgs.br/bitstream/handle/10183/26137/000757143.pdf?sequence=1.

Michelin AP, Maes MHJ, Supasitthumrong T, Limotai, C, Matsumoto AK, Semeão LO, et al. Reduced paraoxonase 1 activities may explain the comorbidities between temporal lobe epilepsy and depression, anxiety and psychosis. World J Psych. 2022;12:308-22. Doi: https://doi.org/10.5498/wjp.v12.i2.308.

Lane C, Crocker C, Legg K, Borden M, Pohlmann-Eden B. Anxiety and Depression in Adult First Seizure Presentations. Canad J Neurol Scien. 2018;45:144-9. Doi: https://doi.org/10.1017/cjn.2017.285.

Rodríguez CA, Kubis MM, Arteaga CBT, Fustes OJH. Psychiatric Comorbidities in Epilepsy. J Epilepsy Res. 2022;12:21-6. Doi: https://doi.org/10.14581/jer.22004.

Published

2024-08-29

Issue

Section

Artigos de Revisão/Review Articles

How to Cite

Dutra, L. S. ., & Darzé Neto, C. (2024). Prevalence of mood disorders and anxiety in people with epilepsy: a systematic review. Revista De Medicina, 103(4), e-226358. https://doi.org/10.11606/issn.1679-9836.v103i4e-226358